Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Revenue - Potential Milestone Payments Received (Details)

v3.24.1.1.u2
Note 3 - Revenue - Potential Milestone Payments Received (Details) - Collaborative Arrangement [Member]
$ in Millions
Mar. 31, 2024
USD ($)
Research And Development Milestone Payments [Member]  
milestone $ 949
Research And Development Milestone Payments [Member] | Pfizer [Member]  
milestone 759
Research And Development Milestone Payments [Member] | Servier Developed Collaboration Products [Member]  
milestone 105
Research And Development Milestone Payments [Member] | Boston Pharmaceuticals [Member]  
milestone 85
Sales Milestone Payments [Member]  
milestone 812
Sales Milestone Payments [Member] | Pfizer [Member]  
milestone 450
Sales Milestone Payments [Member] | Servier Developed Collaboration Products [Member]  
milestone 97
Sales Milestone Payments [Member] | Boston Pharmaceuticals [Member]  
milestone $ 265